NCT03570892
Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT03570892
Title Tisagenlecleucel in Adult Patients With Aggressive B-cell Non-Hodgkin Lymphoma (BELINDA)
Acronym BELINDA
Recruitment Active, not recruiting
Gender both
Phase Phase III
Variant Requirements Yes
Sponsors Novartis Pharmaceuticals
Indications
Therapies
Age Groups: senior | adult
Covered Countries USA | NOR | NLD | ITA | GBR | FRA | ESP | DEU | CHE | BRA | BEL | AUT | AUS

Facility Status City State Zip Country Details
Moores UC San Diego Cancer Center La Jolla California 92093 United States Details
University of California Los Angeles Los Angeles California 90095 United States Details
UCSF Medical Center San Francisco California 94143 United States Details
Sarah Cannon Research Institute Denver Colorado 80218 United States Details
Mayo Clinic Jacksonville Jacksonville Florida 32224 United States Details
Booker Dynamic Brand Solutions Atlanta Georgia 30329 United States Details
Uni of Chi Medi Ctr Hema and Onco Chicago Illinois 60637 United States Details
University of Kansas Cancer Center Kansas City Kansas 66205 United States Details
Wayne State University-Karmanos Cancer Institute Detroit Michigan 48201 United States Details
Uni of Nebraska Med Ctr Omaha Nebraska 68198 United States Details
Hackensack Uni Medical Center Hackensack New Jersey 07601 United States Details
Jewish Hospital Cincinnati Ohio 45236 United States Details
The Ohio State University Columbus Ohio 43210 United States Details
Oregon Health Sciences Univ Portland Oregon 97239 United States Details
Uni Pennsylvania Abramson Cncr Ctr Philadelphia Pennsylvania 19104 United States Details
MUSC Hollings Cancer Center Charleston South Carolina 29425 United States Details
Tennessee Oncology PLLC Chattanooga Tennessee 37404 United States Details
St Davids South Austin Medical Ctr Austin Texas 78704 United States Details
Texas Oncology-Baylor Scott and White Dallas Texas 75231 United States Details
Uni of Texas MD Anderson Ca Center Houston Texas 77030 United States Details
Methodist Hospital San Antonio Texas 78229 United States Details
Uni of Wisconsin Carbone Cancer Ctr Madison Wisconsin 53792-6164 United States Details
Novartis Investigative Site Darlinghurst New South Wales 2010 Australia Details
Novartis Investigative Site Melbourne Victoria 3000 Australia Details
Novartis Investigative Site Murdoch Western Australia 6150 Australia Details
Novartis Investigative Site Salzburg 5020 Austria Details
Novartis Investigative Site Vienna 1090 Austria Details
Novartis Investigative Site Leuven 3000 Belgium Details
Novartis Investigative Site Salvador Estado de Bahia 41253-190 Brazil Details
Novartis Investigative Site São Paulo 05651-901 Brazil Details
Novartis Investigative Site Beijing 100036 China Details
Novartis Investigative Site Beijing 100191 China Details
Novartis Investigative Site Shanghai 200065 China Details
Novartis Investigative Site Lille 59037 France Details
Novartis Investigative Site Montpellier 34295 France Details
Novartis Investigative Site Nantes 44093 France Details
Novartis Investigative Site Paris 75475 France Details
Novartis Investigative Site Pierre-Bénite 69495 France Details
Novartis Investigative Site Toulouse 31059 France Details
Novartis Investigative Site Munich Bavaria 81377 Germany Details
Novartis Investigative Site Regensburg Bavaria 93053 Germany Details
Novartis Investigative Site Cologne North Rhine-Westphalia 50937 Germany Details
Novartis Investigative Site Leipzig Saxony 04103 Germany Details
Novartis Investigative Site Berlin 13353 Germany Details
Novartis Investigative Site Hamburg 20246 Germany Details
Novartis Investigative Site Ulm 89081 Germany Details
Novartis Investigative Site Hong Kong Hong Kong Details
Novartis Investigative Site Milan MI 20133 Italy Details
Novartis Investigative Site Rozzano MI 20089 Italy Details
Novartis Investigative Site Roma RM 00168 Italy Details
Kyushu University Hospital Fukuoka Fukuoka 812-8582 Japan Details
Novartis Investigative Site Fukuoka Fukuoka 812-8582 Japan Details
Hokkaido University Hospital Sapporo Hokkaido 060 8648 Japan Details
Novartis Investigative Site Sapporo Hokkaido 060 8648 Japan Details
Novartis Investigative Site Sendai Miyagi 980 8574 Japan Details
Tohoku University Hospital Sendai Miyagi 980 8574 Japan Details
Novartis Investigative Site Amsterdam North Holland 1081 HV Netherlands Details
Amsterdam UMC, locatie AMC Amsterdam 1105 AZ Netherlands Details
Novartis Investigative Site Utrecht 3584 CX Netherlands Details
UMC Utrecht Cancer Center Utrecht 3584CX Netherlands Details
Novartis Investigative Site Oslo 0310 Norway Details
Novartis Investigative Site Singapore 119074 Singapore Details
Novartis Investigative Site Singapore 169608 Singapore Details
Novartis Investigative Site L'Hospitalet de Llobregat Barcelona 08907 Spain Details
Novartis Investigative Site Salamanca Castille and León 37007 Spain Details
Novartis Investigative Site Barcelona Catalonia 08035 Spain Details
Novartis Investigative Site Madrid 28009 Spain Details
Novartis Investigative Site Madrid 28041 Spain Details
Novartis Investigative Site Zurich 8091 Switzerland Details
Novartis Investigative Site Taipei 10002 Taiwan Details
Novartis Investigative Site London Greater London NW1 2BU United Kingdom Details
Novartis Investigative Site Birmingham West Midlands B15 2TH United Kingdom Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field